O28.5
Abnormal chromosomal and genetic finding on antenatal screening of mother
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code O28.5 refers to abnormal chromosomal and genetic findings identified during antenatal screening of a pregnant mother. These findings can provide important information about the health of the fetus and help healthcare providers plan appropriate care. Such results often stem from specialized testing aimed at detecting potential genetic or chromosomal anomalies before birth.
Causes & Symptoms
Clinical Causes: Genetic mutations passed from parents Chromosomal abnormalities such as extra, missing, or structurally altered chromosomes Inherited genetic syndromes De novo genetic mutations (new mutations not inherited from parents) Environmental factors potentially influencing genetic material during pregnancy Advanced maternal age, which can increase the risk of chromosomal abnormalities
Key Symptoms: Typically no physical symptoms are present in the mother Findings are usually discovered through routine antenatal genetic screening tests Possible indications of fetal anomalies detected via ultrasound or diagnostic testing
Diagnostic & Treatment
Diagnosis Path: The diagnosis begins with routine antenatal screening tests such as combined first-trimester screening or cell-free fetal DNA testing. If these tests indicate potential abnormalities, further diagnostic procedures may be recommended, including:
Treatment Protocols: Management of pregnancies with abnormal genetic or chromosomal findings depends on the specific nature of the findings. It involves a multidisciplinary team approach, including genetic counseling, to interpret results and discuss options. Possible steps include:
Clinical Advice & FAQs
Billing Guidance
Is O28.5 a billable ICD-10 code?
Yes, O28.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O28.5?
Clinical documentation must specify the nature of Abnormal chromosomal and genetic finding on antenatal screening of mother and any associated comorbidities for accurate reporting.
Cite this Clinical Reference